#Nanogen

PSNews – The clinical trials will end in early May 2021, and after that the mass production of “Made-in-Vietnam” COVID-19 vaccine will start, said Mr. Ho Nhan, Chairman of NANOGEN on December 10.

PSNews – The National Ethics Council for Biomedical Research under the Ministry of Health approved phase 1 and phase 2  human trials of the Nanocovax COVID-19 vaccine produced by NANOGEN Company in collaboration with the Military Medical University.

PSNews - As announced in a meeting of the Vietnamese Ministry of Health on December 5, Nanogen will join hands with the Military Medical University to recruit volunteers for the first phase of clinical trial on December 10.